arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

LivaNova PLC

LIVN Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus
$81.92
Today
as of Sep 4, 16:51 ET
Last 30 days -0.21% Jul 28 → Sep 04
$75.02 $77.78 $80.55 $83.32 $86.09 Jul 28 Aug 05 Aug 12 Aug 20 Aug 27 Sep 04
Open
$80.67
High
$82.22
Low
$80.44
Volume
$334,166
Avg Vol
$693,074
Mkt Cap
$4.5B
P/E (TTM)
28.48
Beta
—
52w High
$85.76
52w Low
$48.82
Div Yield
—
Shares Out
$55M

Recent Press Releases & News last 60 days · 17 items

Sep 3 · 13:00 PR Business Wire
LivaNova to Present at Morgan Stanley and Baird Healthcare Conferences in September
Aug 12 · 23:16 Simply Wall St.
Stronger Q2 Results And New Supply Deal Might Change The Case For Investing In LivaNova (LIVN)
Aug 12 · 22:09 Simply Wall St.
LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance
▸ Show all 17 press releases & news Free account →

Overview

52-week range
$49
$86
90% of range
Avg surprise (last 3)
+24.6%
Avg reaction (last 2)
+19.4%
100% positive
Latest IV / EM
37%
EM ±5.8% · $83 · Sep 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.78$-0.10$0.57$1.25$1.93 Actual $0.14Actual $0.02Actual $-0.14Actual $-0.78Actual $0.30Actual $0.60Actual $0.78Est $0.63Actual $0.93Est $0.72Actual $0.49Actual $0.87Est $0.72Actual $1.93 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-327M$-143M$41M$226M$410M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $1.93 — — — — financials
Wed May 6, 2026Mar/2026 $0.87 $0.72 +20.8% +11.5% +15.1% earnings
Tue Sep 30, 2025Sep 2025 $0.49 — — — — financials
Wed Aug 6, 2025Jun/2025 $0.93 $0.72 +29.2% — — earnings
Wed May 7, 2025Mar/2025 $0.78 $0.63 +23.8% — +23.7% earnings
Mon Sep 30, 2024Sep 2024 $0.60 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.30 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.78 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.14 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.02 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.14 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$391M$362M—$358M$353M$317M—$318M
Cost of revenue$117M$119M—$113M$114M$101M—$97M
Gross profit$274M$244M—$245M$239M$216M—$221M
Operating income$49M$41M—$54M$54M$49M—$36M
Net income$109M$22M—$27M$27M$-327M—$33M
EPS (diluted)$1.93$0.40—$0.49$0.50$-6.01—$0.60

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$517M$540M$636M$646M$594M$738M$429M$346M
Inventory$173M$166M$165M$168M$165M$154M$148M$162M
Total current assets$1.03B$1.01B$1.10B$1.10B$1.07B$1.17B$1.13B$1.09B
Total assets$2.64B$2.52B$2.61B$2.56B$2.51B$2.56B$2.51B$2.52B
Long-term debt$290M$285M$345M$349M$348M$549M$550M$604M
Total liabilities$1.32B$1.31B$1.41B$1.40B$1.38B$1.52B$1.19B$1.21B
Total equity$1.33B$1.21B$1.20B$1.16B$1.12B$1.03B$1.32B$1.31B

Implied volatility — last 90 days

33%53%73%92%112% Jun 07 — IV 49% · EM ±6.7%Jun 08 — IV 47% · EM ±6.2%Jun 09 — IV 46% · EM ±5.7%Jun 10 — IV 46% · EM ±5.5%Jun 11 — IV 48% · EM ±5.3%Jun 12 — IV 78% · EM ±8.0%Jun 15 — IV 69% · EM ±5.0%Jun 16 — IV 73% · EM ±4.3%Jun 17 — IV 107% · EM ±4.5%Jun 19 — IV 41% · EM ±9.0%Jun 22 — IV 41% · EM ±8.5%Jun 23 — IV 39% · EM ±8.1%Jun 24 — IV 41% · EM ±8.3%Jun 25 — IV 40% · EM ±7.9%Jun 26 — IV 43% · EM ±8.2%Jun 29 — IV 40% · EM ±7.1%Jun 30 — IV 41% · EM ±7.0%Jul 01 — IV 39% · EM ±6.5%Jul 02 — IV 43% · EM ±6.9%Jul 03 — IV 44% · EM ±6.9%Jul 06 — IV 45% · EM ±6.3%Jul 07 — IV 42% · EM ±5.6%Jul 08 — IV 43% · EM ±5.4%Jul 09 — IV 44% · EM ±5.2%Jul 10 — IV 47% · EM ±5.2%Jul 13 — IV 48% · EM ±4.0%Jul 14 — IV 52% · EM ±3.8%Jul 16 — IV 113% · EM ±4.7%Jul 20 — IV 53% · EM ±12.5%Jul 21 — IV 49% · EM ±11.4%Jul 22 — IV 53% · EM ±12.1%Jul 23 — IV 52% · EM ±11.8%Jul 24 — IV 52% · EM ±11.4%Jul 27 — IV 53% · EM ±11.1%Jul 28 — IV 50% · EM ±10.2%Jul 29 — IV 52% · EM ±10.4%Jul 30 — IV 53% · EM ±10.4%Jul 31 — IV 57% · EM ±10.9%Aug 03 — IV 58% · EM ±10.3%Aug 04 — IV 53% · EM ±9.1%Aug 05 — IV 41% · EM ±6.8%Aug 06 — IV 41% · EM ±6.6%Aug 07 — IV 42% · EM ±6.5%Aug 10 — IV 46% · EM ±6.4%Aug 11 — IV 42% · EM ±5.6%Aug 12 — IV 39% · EM ±4.9%Aug 13 — IV 40% · EM ±4.7%Aug 14 — IV 43% · EM ±4.7%Aug 17 — IV 71% · EM ±6.0%Aug 18 — IV 82% · EM ±6.0%Aug 19 — IV 63% · EM ±3.7%Aug 20 — IV 74% · EM ±3.1%Aug 24 — IV 38% · EM ±8.0%Aug 25 — IV 37% · EM ±7.6%Aug 26 — IV 37% · EM ±7.4%Aug 27 — IV 34% · EM ±6.7%Aug 28 — IV 35% · EM ±6.7%Aug 31 — IV 34% · EM ±6.0%Sep 01 — IV 34% · EM ±5.9%Sep 02 — IV 36% · EM ±5.9%Sep 03 — IV 39% · EM ±6.3%Sep 04 — IV 37% · EM ±5.8%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,148.00-0.1%
JNJ
Johnson & Johnson
$671.0B $275.71+0.2%
ABBV
AbbVie Inc.
$430.9B $256.50+0.1%
MRK
Merck & Company, Inc.
$317.1B $150.33+0.0%
PM
Philip Morris International Inc
$299.3B $182.53+0.0%
NVS
Novartis AG
$297.9B $155.11-3.0%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in